97423939 - EMRUSOLMIN

Information

• Trademark
• 97423939

• Source

• Serial Number

  97423939

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  May 23, 2022
  2 years ago

• Transaction Date

  June 30, 2022
  2 years ago

• Status Date

  June 30, 2022
  2 years ago

• Location Date

  June 27, 2022
  2 years ago

• Status Code

  601

• Current Location

  TMEG LAW OFFICE 101

• Attorney Docket Number

  14240008TM

  Attorney Name

  Timothy J. Maier

• Owners

  • MODAG GmbH

Case File Statements

• GS0051: Medicines for human purposes; Medicines for veterinary purposes; Pharmaceuticals and natural remedies; Medicines for the treatment of Alzheimer's disease; Medicines for the treatment of neurodegenerative diseases; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Chemico-pharmaceutical preparations; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations and materials; Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medical use; Dragees; Injectable pharmaceuticals; Medicinal preparations and substances; Antiparkinson agents; Pharmaceutical drugs; Pharmaceuticals; Pharmaceutical preparations for human use; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment of Alzeimer's disease; Pharmaceutical preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for the treatment of cerebral disease; Pharmaceutical preparations for the treatment of central nervous system diseases
• GS0441: Medication counseling; Providing information to patients in the field of administering medications; Provision of information relating to pharmaceutical products; Provision of information relating to the treatment of degenerative diseases; Provision of information relating to medical services; Provision of pharmaceutical information; Advisory services relating to the treatment of degenerative diseases; Consultancy and information services relating to pharmaceutical products; Consultancy and information services provided via the Internet relating to pharmaceutical products; Consultancy and information services relating to medical products; Advisory services relating to medicines; Medical services; Medical services for treating Alzheimer's disease; Pharmaceutical services; Preparation and dispensing of medications
• GS0421: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consultancy relating to pharmaceutical research and development; Biological research, clinical research and medical research; Medical research laboratory services; Testing of pharmaceuticals; Analysis of human serum for medical research; Analysis of human tissues for medical research; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Research and development of vaccines and medicines; Providing scientific information in the field of medical disorders and their treatment; Research in the field of pharmacogenetics; Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Clinical research; Laboratory research services relating to pharmaceuticals; Medical research; Medical and pharmacological research services; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Inspection of pharmaceuticals; Scientific research in the field of pharmacy; Scientific research and development

Case File Event Statements

• 6/30/2022 - 2 years ago

  8 - ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT Type: MAB1

• 6/30/2022 - 2 years ago

  7 - ABANDONMENT - EXPRESS MAILED Type: ABN1

• 6/29/2022 - 2 years ago

  6 - TEAS EXPRESS ABANDONMENT RECEIVED Type: EXAR

• 6/27/2022 - 2 years ago

  5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 6/27/2022 - 2 years ago

  4 - ASSIGNED TO LIE Type: ALIE

• 6/14/2022 - 2 years ago

  3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 5/27/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 5/27/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP